Showing results (591-600 of 1,644) with videos related to

Sort By:
Pageof 165
Clinical and Experimental Dermatology|July 30, 2025
Greater topical corticosteroid quantity applied reduces severity of psoriasis: Results from two randomized controlled trialsMathias Tiedemann Svendsen, Sören Möller, Steven R Feldman, et al.
Dermatology Online Journal|September 23, 2014
Increasing use of non-traditional vehicles for psoriasis and other inflammatory skin conditionsKaren E Huang, Scott A Davis, Jacob Cantrell, et al.
The Urologic Clinics of North America|July 29, 2015
Late Relapse of Testicular Germ Cell TumorsMatthew J O'Shaughnessy, Darren R Feldman, Brett S Carver, et al.
Children (Basel, Switzerland)|September 14, 2019
Biologic Treatment Options for Pediatric Psoriasis and Atopic DermatitisAbigail Cline, Gregory J Bartos, Lindsay C Strowd, et al.
Skinmed|October 28, 2016
First-Line Fixed-Combination Psoriasis Treatment Is Associated With Lower Healthcare CostsSteven R Feldman, Eugenia Levi, Prathamesh Pathak, et al.
Journal of the American Academy of Dermatology|April 4, 2008
To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasisWilliam Huang, Kelly M Cordoro, Sarah L Taylor, et al.
Journal of the American Academy of Dermatology|June 3, 2008
Written action plans: potential for improving outcomes in children with atopic dermatitisSarah S Chisolm, Sarah L Taylor, Rajesh Balkrishnan, et al.
Dermatologic Clinics|May 25, 2024
Adherence to Psoriasis TherapiesKawaiola C Aoki, Summer Wong, Jessica Q Duong, et al.
Archives of Dermatological Research|July 11, 2023
Recurrence rates in the treatment of keloids and hypertrophic scars with intralesional triamcinolone combined with other intralesional agentsSarah N Rimmer, Rithi J Chandy, Danyaal Khan, et al.
Expert Review of Clinical Immunology|July 31, 2026
Ustekinumab for the treatment of psoriasis: a well-established therapy primed for resurgenceOmar Raheel, Alexander Uche, Pauline Do, et al.
Pageof 165